2017
DOI: 10.1016/j.jconrel.2017.01.047
|View full text |Cite
|
Sign up to set email alerts
|

Strategies for improving the payload of small molecular drugs in polymeric micelles

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
78
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 101 publications
(81 citation statements)
references
References 126 publications
0
78
0
Order By: Relevance
“…[78][79][80] The core-shell structure of the polymer micelles can be varied by changing the composition of the monomers in the polymer chain. 81,82 The core of polymeric micelles is composed of densely packed polymer matrix, which can be filled with hydrophobic drugs. 83 This structure enables the polymer micelles to be utilized as suitable and effective nanocarriers.…”
Section: Polymeric Micellesmentioning
confidence: 99%
“…[78][79][80] The core-shell structure of the polymer micelles can be varied by changing the composition of the monomers in the polymer chain. 81,82 The core of polymeric micelles is composed of densely packed polymer matrix, which can be filled with hydrophobic drugs. 83 This structure enables the polymer micelles to be utilized as suitable and effective nanocarriers.…”
Section: Polymeric Micellesmentioning
confidence: 99%
“…argued that the low drug loading capacity and poor in vivo stability typically displayed by polymeric micelles is responsible for this major discrepancy. [10] These major problems concerning nanoformulations, drug delivery and the advancement of polymeric micelles for clinical cancer therapy were also critically reviewed by other researchers. [11][12][13] Polymer micelles comprising a poly(2-oxazoline) (POx) based amphiphilic triblock copolymer (poly(2-methyl-2-oxazoline)-block-poly(2-butyl-2-oxazoline)-block-poly(2-methyl-2oxazoline) (PMeOx-b-PBuOx-b-PMeOx ≡ A-pBuOx-A)) constitute an unusual exception.…”
Section: Introductionmentioning
confidence: 99%
“…11 Unfortunately, these formulations are often plagued with a low drug loading and instability in vivo. [12][13][14] Strategies to circumvent this limitation include adjustment of the hydrophobic-hydrophilic balance, [15][16][17] improvement of the polymer-drug interactions, [18][19][20][21] cross-linking, [22][23][24][25] or conjugation of the drug to the polymer via covalent bonding. 15,[26][27][28][29] However, these strategies are often met with challenges, particularly slow, insufficient release.…”
Section: Introductionmentioning
confidence: 99%